{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:32:32Z","timestamp":1791181952264,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T00:00:00Z","timestamp":1225756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T00:00:00Z","timestamp":1225756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/ncpendmet1005","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T07:56:43Z","timestamp":1225785403000},"page":"675-682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treating fetal thyroid and adrenal disorders through the mother"],"prefix":"10.1038","volume":"4","author":[{"given":"Guy","family":"Van Vliet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Martin","family":"Ritz\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,4]]},"reference":[{"key":"BFncpendmet1005_CR1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-2265.2006.02577.x","volume":"65","author":"C Di Cosmo","year":"2006","unstructured":"Di Cosmo C  et al. (2006) The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study. Clin Endocrinol (Oxf) 65: 544\u2013548","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet1005_CR2","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1056\/NEJM199412293312603","volume":"331","author":"XY Cao","year":"1994","unstructured":"Cao XY  et al. (1994) Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med 331: 1739\u20131744","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/105072501300176390","volume":"11","author":"F Delange","year":"2001","unstructured":"Delange F  et al. (2001) Iodine deficiency in the world: where do we stand at the turn of the century. Thyroid 11: 437\u2013447","journal-title":"Thyroid"},{"key":"BFncpendmet1005_CR4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1017\/S1368980007360886","volume":"10","author":"D Glinoer","year":"2007","unstructured":"Glinoer D (2007) The importance of iodine nutrition during pregnancy. Public Health Nutr 10: 1542\u20131546","journal-title":"Public Health Nutr"},{"key":"BFncpendmet1005_CR5","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1210\/jcem.87.4.8434","volume":"87","author":"RM Calvo","year":"2002","unstructured":"Calvo RM  et al. (2002) Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87: 1768\u20131777","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM198907063210103","volume":"321","author":"T Vulsma","year":"1989","unstructured":"Vulsma T  et al. (1989) Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid agenesis. N Engl J Med 321: 13\u201316","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jama.292.6.691","volume":"292","author":"J Anselmo","year":"2004","unstructured":"Anselmo J  et al. (2004) Fetal loss associated with excess thyroid hormone exposure. JAMA 292: 691\u2013695","journal-title":"JAMA"},{"key":"BFncpendmet1005_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1677\/joe.1.06582","volume":"189","author":"SY Chan","year":"2006","unstructured":"Chan SY  et al. (2006) Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol 189: 465\u2013471","journal-title":"J Endocrinol"},{"key":"BFncpendmet1005_CR9","first-page":"3127","volume":"80","author":"F de Zegher","year":"1995","unstructured":"de Zegher F  et al. (1995) The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 80: 3127\u20133130","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJM199908193410801","volume":"341","author":"JE Haddow","year":"1999","unstructured":"Haddow JE  et al. (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341: 549\u2013555","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1365-2265.1999.00639.x","volume":"50","author":"VJ Pop","year":"1999","unstructured":"Pop VJ  et al. (1999) Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 50: 147\u2013148","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet1005_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/thy.2000.10.871","volume":"10","author":"D Glinoer","year":"2000","unstructured":"Glinoer D and Delange F (2000) The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid 10: 871\u2013887","journal-title":"Thyroid"},{"key":"BFncpendmet1005_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa040079","volume":"351","author":"EK Alexander","year":"2004","unstructured":"Alexander EK  et al. (2004) Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351: 241\u2013249","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1507\/endocrj.K07-047","volume":"54","author":"I Miyata","year":"2007","unstructured":"Miyata I  et al. (2007) Successful intrauterine therapy for fetal goitrous hypothyroidism during late gestation. Endocr J 54: 813\u2013817","journal-title":"Endocr J"},{"key":"BFncpendmet1005_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ajog.2005.01.060","volume":"193","author":"K Borgel","year":"2005","unstructured":"Borgel K  et al. (2005) Intrauterine therapy of goitrous hypothyroidism in a boy with a new compound heterozygous mutation (Y453D and C800R) in the thyroid peroxidase gene: a long-term follow-up. Am J Obstet Gynecol 193: 857\u2013858","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpendmet1005_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1172\/JCI114790","volume":"86","author":"R Calvo","year":"1990","unstructured":"Calvo R  et al. (1990) Congenital hypothyroidism, as studied in rats: crucial role of maternal thyroxine but not of 3,5,3'-triiodothyronine in the protection of the fetal brain. J Clin Invest 86: 889\u2013899","journal-title":"J Clin Invest"},{"key":"BFncpendmet1005_CR17","first-page":"222","volume":"81","author":"JM Dubuis","year":"1996","unstructured":"Dubuis JM  et al. (1996) Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab 81: 222\u2013227","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jpeds.2004.02.021","volume":"144","author":"J Simoneau-Roy","year":"2004","unstructured":"Simoneau-Roy J  et al. (2004) Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J Pediatr 144: 747\u2013752","journal-title":"J Pediatr"},{"key":"BFncpendmet1005_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1210\/jcem-71-3-618","volume":"71","author":"AH Perelman","year":"1990","unstructured":"Perelman AH  et al. (1990) Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism. J Clin Endocrinol Metab 71: 618\u2013621","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1056\/NEJM199102213240807","volume":"324","author":"KM Davidson","year":"1991","unstructured":"Davidson KM  et al. (1991) Successful in utero treatment of fetal goiter and hypothyroidism. N Engl J Med 324: 543\u2013546","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.beem.2004.03.009","volume":"18","author":"M Polak","year":"2004","unstructured":"Polak M  et al. (2004) Fetal and neonatal thyroid function in relation to maternal Graves' disease. Best Pract Res Clin Endocrinol Metab 18: 289\u2013302","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1210\/jcem-57-5-1036","volume":"57","author":"M Zakarija","year":"1983","unstructured":"Zakarija M and McKenzie JM (1983) Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 57: 1036\u20131040","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.0954-6820.1984.tb17679.x","volume":"215","author":"FA Karlsson","year":"1984","unstructured":"Karlsson FA  et al. (1984) Thyroid blocking antibodies in thyroiditis. Acta Med Scand 215: 461\u2013466","journal-title":"Acta Med Scand"},{"key":"BFncpendmet1005_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0022-3476(95)70308-X","volume":"127","author":"D Pacaud","year":"1995","unstructured":"Pacaud D  et al. (1995) Outcome in three siblings with antibody-mediated transient congenital hypothyroidism. J Pediatr 127: 275\u2013277","journal-title":"J Pediatr"},{"key":"BFncpendmet1005_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJM199501193320304","volume":"332","author":"P Kopp","year":"1995","unstructured":"Kopp P  et al. (1995) Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 332: 150\u2013154","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR26","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1172\/JCI119687","volume":"100","author":"P Kopp","year":"1997","unstructured":"Kopp P  et al. (1997) Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100: 1634\u20131639","journal-title":"J Clin Invest"},{"key":"BFncpendmet1005_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ng0794-396","volume":"7","author":"L Duprez","year":"1994","unstructured":"Duprez L  et al. (1994) Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7: 396\u2013401","journal-title":"Nat Genet"},{"key":"BFncpendmet1005_CR28","first-page":"2023","volume":"81","author":"N de Roux","year":"1996","unstructured":"de Roux N  et al. (1996) A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81: 2023\u20132026","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR29","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1210\/jc.2004-2555","volume":"90","author":"D Luton","year":"2005","unstructured":"Luton D  et al. (2005) Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 90: 6093\u20136098","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7863\/jum.2001.20.6.613","volume":"20","author":"AC Ranzini","year":"2001","unstructured":"Ranzini AC  et al. (2001) Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. J Ultrasound Med 20: 613\u2013617","journal-title":"J Ultrasound Med"},{"key":"BFncpendmet1005_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ajmg.a.30418","volume":"132A","author":"N Foulds","year":"2004","unstructured":"Foulds N  et al. (2004) Carbimazole embryopathy: an emerging phenotype. Am J Med Genet 132A: 130\u2013135","journal-title":"Am J Med Genet"},{"key":"BFncpendmet1005_CR32","first-page":"1145","volume":"78","author":"A Wedell","year":"1994","unstructured":"Wedell A  et al. (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78: 1145\u20131152","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10508-007-9265-1","volume":"37","author":"HF Meyer-Bahlburg","year":"2008","unstructured":"Meyer-Bahlburg HF  et al. (2008) Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav 37: 85\u201399","journal-title":"Arch Sex Behav"},{"key":"BFncpendmet1005_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0022-3476(84)80310-8","volume":"105","author":"M David","year":"1984","unstructured":"David M and Forest MG (1984) Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 105: 799\u2013803","journal-title":"J Pediatr"},{"key":"BFncpendmet1005_CR35","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1210\/jcem.86.12.8072","volume":"86","author":"MI New","year":"2001","unstructured":"New MI  et al. (2001) Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86: 5651\u20135657","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR36","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser PW and White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349: 776\u2013788","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000111058","volume":"11","author":"L Ghizzoni","year":"2007","unstructured":"Ghizzoni L  et al. (2007) Prenatal and early postnatal treatment of congenital adrenal hyperplasia. Endocr Dev 11: 58\u201369","journal-title":"Endocr Dev"},{"key":"BFncpendmet1005_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ncpendmet0481","volume":"3","author":"S Nimkarn","year":"2007","unstructured":"Nimkarn S and New MI (2007) Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nat Clin Pract Endocrinol Metab 3: 405\u2013413","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"BFncpendmet1005_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0960-0760(93)90125-G","volume":"45","author":"MG Forest","year":"1993","unstructured":"Forest MG  et al. (1993) Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 45: 75\u201382","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFncpendmet1005_CR40","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1001\/jama.1997.03540370067039","volume":"277","author":"JR Seckl","year":"1997","unstructured":"Seckl JR and Miller WL (1997) How safe is long-term prenatal glucocorticoid treatment. JAMA 277: 1077\u20131079","journal-title":"JAMA"},{"key":"BFncpendmet1005_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0022-5347(05)68624-7","volume":"162","author":"WL Miller","year":"1999","unstructured":"Miller WL (1999) Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety. J Urol 162: 537\u2013540","journal-title":"J Urol"},{"key":"BFncpendmet1005_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0079-6123(07)67002-2","volume":"167","author":"JR Seckl","year":"2008","unstructured":"Seckl JR (2008) Glucocorticoids, developmental 'programming' and the risk of affective dysfunction. Prog Brain Res 167: 17\u201334","journal-title":"Prog Brain Res"},{"key":"BFncpendmet1005_CR43","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/humrep\/deg320","volume":"18","author":"J Guibert","year":"2003","unstructured":"Guibert J  et al. (2003) Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique. Hum Reprod 18: 1733\u20131736","journal-title":"Hum Reprod"},{"key":"BFncpendmet1005_CR44","first-page":"3872","volume":"83","author":"S Lajic","year":"1998","unstructured":"Lajic S  et al. (1998) Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 83: 3872\u20133880","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1203\/00006450-199809000-00009","volume":"44","author":"G Celsi","year":"1998","unstructured":"Celsi G  et al. (1998) Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 44: 317\u2013322","journal-title":"Pediatr Res"},{"key":"BFncpendmet1005_CR46","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1152\/ajpregu.00012.2004","volume":"287","author":"CR Neal Jr","year":"2004","unstructured":"Neal CR Jr  et al. (2004) Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am J Physiol Regul Integr Comp Physiol 287: R375\u2013R385","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFncpendmet1005_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2005.11.015","volume":"28","author":"M Emgard","year":"2007","unstructured":"Emgard M  et al. (2007) Prenatal glucocorticoid exposure affects learning and vulnerability of cholinergic neurons. Neurobiol Aging 28: 112\u2013121","journal-title":"Neurobiol Aging"},{"key":"BFncpendmet1005_CR48","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/0002-9378(83)90841-4","volume":"145","author":"MJ Novy","year":"1983","unstructured":"Novy MJ and Walsh SW (1983) Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth. Am J Obstet Gynecol 145: 920\u2013931","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpendmet1005_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0165-3806(90)90002-G","volume":"53","author":"H Uno","year":"1990","unstructured":"Uno H  et al. (1990) Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 53: 157\u2013167","journal-title":"Brain Res Dev Brain Res"},{"key":"BFncpendmet1005_CR50","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1006\/hbeh.1994.1030","volume":"28","author":"H Uno","year":"1994","unstructured":"Uno H  et al. (1994) Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 28: 336\u2013348","journal-title":"Horm Behav"},{"key":"BFncpendmet1005_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0002-9378(99)70160-2","volume":"180","author":"NP French","year":"1999","unstructured":"French NP  et al. (1999) Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180: 114\u2013121","journal-title":"Am J Obstet Gynecol"},{"key":"BFncpendmet1005_CR52","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1056\/NEJMoa032089","volume":"350","author":"TF Yeh","year":"2004","unstructured":"Yeh TF  et al. (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350: 1304\u20131313","journal-title":"N Engl J Med"},{"key":"BFncpendmet1005_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00060793-199706000-00005","volume":"4","author":"MG Forest","year":"1997","unstructured":"Forest MG (1997) Prenatal diagnosis, treatment, and outcome in infants with congenital adrenal hyperplasia. Current Opinion in Endocrinology and Diabetology 4: 209\u2013217","journal-title":"Current Opinion in Endocrinology and Diabetology"},{"key":"BFncpendmet1005_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0960-0760(99)00059-X","volume":"69","author":"AD Carlson","year":"1999","unstructured":"Carlson AD  et al. (1999) Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol 69: 19\u201329","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFncpendmet1005_CR55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0306-4530(94)00070-0","volume":"20","author":"PD Trautman","year":"1995","unstructured":"Trautman PD  et al. (1995) Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 20: 439\u2013449","journal-title":"Psychoneuroendocrinology"},{"key":"BFncpendmet1005_CR56","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1210\/jc.2002-021129","volume":"89","author":"HF Meyer-Bahlburg","year":"2004","unstructured":"Meyer-Bahlburg HF  et al. (2004) Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone. J Clin Endocrinol Metab 89: 610\u2013614","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1005_CR57","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1210\/jc.2006-1340","volume":"92","author":"T Hirvikoski","year":"2007","unstructured":"Hirvikoski T  et al. (2007) Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone. J Clin Endocrinol Metab 92: 542\u2013548","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1005","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:57:41Z","timestamp":1684439861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet1005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,4]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFncpendmet1005"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet1005","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,4]]},"assertion":[{"value":"9 May 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}